Research ArticleMetabolism, Transport, and Pharmacogenomics
Two Naturally Occurring Mutations in the Type 1 Melanin-Concentrating Hormone Receptor Abolish Agonist-Induced Signaling
Carmit Goldstein, Jonathan C. Schroeder, Jean-Philippe Fortin, Jennifer M. Goss, Scott E. Schaus, Martin Beinborn and Alan S. Kopin
Journal of Pharmacology and Experimental Therapeutics December 2010, 335 (3) 799-806; DOI: https://doi.org/10.1124/jpet.110.174029
Carmit Goldstein
Jonathan C. Schroeder
Jean-Philippe Fortin
Jennifer M. Goss
Scott E. Schaus
Martin Beinborn
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMetabolism, Transport, and Pharmacogenomics
Two Naturally Occurring Mutations in the Type 1 Melanin-Concentrating Hormone Receptor Abolish Agonist-Induced Signaling
Carmit Goldstein, Jonathan C. Schroeder, Jean-Philippe Fortin, Jennifer M. Goss, Scott E. Schaus, Martin Beinborn and Alan S. Kopin
Journal of Pharmacology and Experimental Therapeutics December 1, 2010, 335 (3) 799-806; DOI: https://doi.org/10.1124/jpet.110.174029
Research ArticleMetabolism, Transport, and Pharmacogenomics
Two Naturally Occurring Mutations in the Type 1 Melanin-Concentrating Hormone Receptor Abolish Agonist-Induced Signaling
Carmit Goldstein, Jonathan C. Schroeder, Jean-Philippe Fortin, Jennifer M. Goss, Scott E. Schaus, Martin Beinborn and Alan S. Kopin
Journal of Pharmacology and Experimental Therapeutics December 1, 2010, 335 (3) 799-806; DOI: https://doi.org/10.1124/jpet.110.174029
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement